Advertisement
Research Article Free access | 10.1172/JCI106258
Diabetes Research Laboratory, Veterans Administration Hospital, Washington, D. C. 20422
Georgetown University, Washington, D. C. 20007
Find articles by Lazarus, N. in: JCI | PubMed | Google Scholar
Diabetes Research Laboratory, Veterans Administration Hospital, Washington, D. C. 20422
Georgetown University, Washington, D. C. 20007
Find articles by Penhos, J. in: JCI | PubMed | Google Scholar
Diabetes Research Laboratory, Veterans Administration Hospital, Washington, D. C. 20422
Georgetown University, Washington, D. C. 20007
Find articles by Tanese, T. in: JCI | PubMed | Google Scholar
Diabetes Research Laboratory, Veterans Administration Hospital, Washington, D. C. 20422
Georgetown University, Washington, D. C. 20007
Find articles by Michaels, L. in: JCI | PubMed | Google Scholar
Diabetes Research Laboratory, Veterans Administration Hospital, Washington, D. C. 20422
Georgetown University, Washington, D. C. 20007
Find articles by Gutman, R. in: JCI | PubMed | Google Scholar
Diabetes Research Laboratory, Veterans Administration Hospital, Washington, D. C. 20422
Georgetown University, Washington, D. C. 20007
Find articles by Recant, L. in: JCI | PubMed | Google Scholar
Published March 1, 1970 - More info
The biological activity of purified porcine proinsulin was investigated in rats. In vivo studies revealed that proinsulin produced a hypoglycemic response similar to insulin but of lesser magnitude. Hypophysectomized and adrenalectomized animals proved to be more sensitive to proinsulin than normal. In vitro studies with rat hemidiaphragm were consistent with the in vivo findings. No competition with insulin action could be demonstrated.
Experiments were carried out to determine whether proinsulin is converted to intermediate forms or insulin as a requisite to its biological activity. Labeled proinsulin injected in vivo or incubated in vitro remained intact by a variety of techniques (Sephadex column chromatography and polyacrylamide-gel electrophoresis).
An inhibitory action of Kunitz pancreatic trypsin inhibitor on proinsulin action in vitro was confirmed. No clarification of this effect could be ascertained.
Images.